n-methylaspartate has been researched along with neuropeptide y in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (11.11) | 18.7374 |
| 1990's | 22 (61.11) | 18.2507 |
| 2000's | 6 (16.67) | 29.6817 |
| 2010's | 3 (8.33) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| de Montigny, C; Debonnel, G; Fournier, A; Monnet, FP | 2 |
| Colmers, WF; McQuiston, AR | 1 |
| Itakura, T; Komai, N; Naka, Y; Nakai, K; Okuno, T; Ueno, M; Yokote, H | 1 |
| Junien, JL; Pascaud, X; Porreca, F; Rivière, PJ | 1 |
| Duffy, O; Junien, JL; Pascaud, X; Roman, FJ | 1 |
| de Montigny, C; Debonnel, G; Monnet, FP | 1 |
| Beal, MF; Ferrante, RJ; Kowall, NW; Martin, JB; Swartz, KJ | 1 |
| Johnson, RF; Moore, RY; Morin, LP | 1 |
| Arcavi, LJ; Ferriero, DM; McIntosh, TK; Sagar, SM; Simon, RP | 1 |
| Beart, PM; Christie, MJ; Jarrott, B; Maccarrone, C | 1 |
| Hamada, T; Ono, M; Shibata, S; Watanabe, A; Watanabe, S | 1 |
| Kent, G; Liu, JL; Papachristou, DN; Patel, SC; Patel, YC; Warszynska, A | 1 |
| Kadlec, O; Schuurkes, J; Seferna, I | 1 |
| Albala, N; Halleux, P; Jacobs, O; Mailleux, P; Schiffmann, SN; Van Bree, L; Vanderhaeghen, JJ; Zhang, F | 1 |
| Kerkerian-Le Goff, L; Nieoullon, A; Salin, P | 1 |
| Bergeron, R; de Montigny, C; Debonnel, G; Gronier, B; Monnet, FP | 1 |
| Fukuhara, C; Inouye, SI; Otori, Y; Shinohara, K; Tominaga, K | 1 |
| Park, SK; Selmanoff, M | 1 |
| Bergeron, R; De Montigny, C; Debonnel, G; Monnet, FP | 1 |
| Böhmer, G; Schmahl, C | 1 |
| Ault, DT; Werling, LL | 2 |
| Ault, DT; Radeff, JM; Werling, LL | 1 |
| Schwarzer, C; Sperk, G | 1 |
| Grillner, S; Parker, D; Svensson, E; Ullström, M | 1 |
| Parker, D | 1 |
| Harrington, ME; Yannielli, PC | 1 |
| Brewer, JM; Harrington, ME; Yannielli, PC | 1 |
| Kumar, U | 1 |
| Albers, HE; Gamble, KL; Novak, CM | 1 |
| Harrington, ME; Soscia, SJ | 1 |
| Kawabe, K; Kawabe, T; Sapru, HN | 2 |
| He, Y; Hinton, A; Liu, C; Saito, K; Shu, G; Tong, Q; Wang, C; Wu, Q; Xia, Y; Xu, P; Xu, Y; Yan, X; Yang, Y | 1 |
| Copland, DA; Dick, AD; Li, Y; Liu, J; Liu, L; Mertsch, S; Ou, K; Schrader, S; Theodoropoulou, S | 1 |
36 other study(ies) available for n-methylaspartate and neuropeptide y
| Article | Year |
|---|---|
Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
Topics: Animals; Drug Synergism; Hippocampus; Male; N-Methylaspartate; Neuropeptide Y; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Structure-Activity Relationship | 1992 |
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
Topics: Animals; Cinnamates; Cyclopropanes; Drug Synergism; Guanidines; Haloperidol; Hippocampus; Male; N-Methylaspartate; Neuropeptide Y; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Receptors, sigma; Spiperone | 1992 |
Neuropeptide Y does not alter NMDA conductances in CA3 pyramidal neurons: a slice-patch study.
Topics: Animals; Electric Conductivity; Hippocampus; In Vitro Techniques; Iontophoresis; Male; N-Methylaspartate; Neurons; Neuropeptide Y; Rats; Rats, Inbred Strains | 1992 |
[Selective vulnerability of peptide-containing neurons in cerebral ischemia; immunohistochemical study].
Topics: Animals; Brain Ischemia; Catecholamines; Cerebral Cortex; Gerbillinae; Immunohistochemistry; N-Methylaspartate; Neurons; Neuropeptide Y; Neuropeptides; Somatostatin; Vasoactive Intestinal Peptide | 1991 |
Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site.
Topics: Animals; Cinnamates; Cyclopropanes; Haloperidol; In Vitro Techniques; Intestinal Mucosa; Intestines; Ion Channels; Male; Mice; Mice, Inbred ICR; N-Methylaspartate; Neuropeptide Y; Receptors, Opioid; Receptors, Opioid, delta | 1990 |
N-methyl-D-aspartate receptor complex modulation by neuropeptide Y and peptide YY in rat hippocampus in vitro.
Topics: Animals; Gastrointestinal Hormones; Hippocampus; In Vitro Techniques; Kinetics; Male; N-Methylaspartate; Neuropeptide Y; Norepinephrine; Peptide YY; Peptides; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |
Neuropeptide Y selectively potentiates N-methyl-D-aspartate-induced neuronal activation.
Topics: Animals; Aspartic Acid; Drug Synergism; Haloperidol; Iontophoresis; Kainic Acid; Male; N-Methylaspartate; Neurons; Neuropeptide Y; Oxadiazoles; Quisqualic Acid; Rats; Rats, Inbred Strains | 1990 |
Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
Topics: Animals; Aspartic Acid; Cholinergic Fibers; Corpus Striatum; Dose-Response Relationship, Drug; Kainic Acid; Male; N-Methylaspartate; NADPH Dehydrogenase; Neuropeptide Y; Pyridines; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Receptors, Glutamate; Receptors, Neurotransmitter; Somatostatin | 1989 |
Lateral geniculate lesions alter circadian activity rhythms in the hamster.
Topics: Animals; Aspartic Acid; Circadian Rhythm; Cricetinae; Geniculate Bodies; Male; Motor Activity; N-Methylaspartate; Neuropeptide Y | 1989 |
Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia.
Topics: Animals; Animals, Newborn; Aspartic Acid; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Hypoxia; N-Methylaspartate; NADH, NADPH Oxidoreductases; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Rats; Rats, Inbred Strains; Somatostatin | 1988 |
Distribution of neuropeptide Y immunoreactivity in the rat basal ganglia: effects of excitotoxin lesions to caudate-putamen.
Topics: Animals; Aspartic Acid; Basal Ganglia; Brain Diseases; Caudate Nucleus; Male; N-Methylaspartate; Nerve Tissue Proteins; Neuropeptide Y; Putamen; Radioimmunoassay; Rats; Rats, Inbred Strains; Tissue Distribution | 1986 |
N-methyl-D-aspartate induces phase shifts in circadian rhythm of neuronal activity of rat SCN in vitro.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Circadian Rhythm; Dizocilpine Maleate; Electrophysiology; In Vitro Techniques; N-Methylaspartate; Neurons; Neuropeptide Y; Quinoxalines; Rats; Rats, Wistar; Suprachiasmatic Nucleus | 1994 |
Differential stimulation of somatostatin but not neuropeptide Y gene expression by quinolinic acid in cultured cortical neurons.
Topics: Animals; Cells, Cultured; Cerebral Cortex; Cyclic AMP-Dependent Protein Kinases; Fetus; Gene Expression; Hypothalamus; N-Methylaspartate; Neurons; Neuropeptide Y; Protein Kinase C; Quinolinic Acid; Rats; RNA, Messenger; Signal Transduction; Somatostatin | 1995 |
The topographical basis and frequency-dependence in the effect of different compounds on neurogenic contractions of the guinea-pig ileum.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Cisapride; Electric Stimulation; Electrophysiology; Glutamates; Glutamic Acid; Glycine; Guinea Pigs; Ileum; In Vitro Techniques; Male; Mollusk Venoms; Muscle Contraction; N-Methylaspartate; Neuropeptide Y; omega-Conotoxin GVIA; Peptides; Piperidines; Potassium; Sodium; Synapses | 1993 |
Homolateral cerebrocortical increase of immediate early gene and neurotransmitter messenger RNAs after minimal cortical lesion: blockade by N-methyl-D-aspartate antagonist.
Topics: Animals; Cerebral Cortex; Cerebral Infarction; Cholecystokinin; Dizocilpine Maleate; DNA-Binding Proteins; Early Growth Response Protein 1; Female; Gene Expression Regulation; Genes, fos; Genes, Immediate-Early; Genes, jun; Glutamate Decarboxylase; Glutamates; Glutamic Acid; Immediate-Early Proteins; Leucine Zippers; Membrane Proteins; N-Methylaspartate; Nerve Tissue Proteins; Neuropeptide Y; Neurotransmitter Agents; Nuclear Receptor Subfamily 4, Group A, Member 1; Parietal Lobe; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Somatostatin; Time Factors; Transcription Factors; Zinc Fingers | 1994 |
Reversal of the adaptive response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-D-aspartate antagonist dizocilpine maleate.
Topics: Adaptation, Physiological; Animals; Behavior, Animal; Dizocilpine Maleate; Female; Immunohistochemistry; N-Methylaspartate; Neostriatum; Neural Pathways; Neurons; Neurons, Afferent; Neuropeptide Y; Oxidopamine; Rats; Rats, Wistar; Substantia Nigra; Synaptic Transmission | 1994 |
The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
Topics: Animals; Anticonvulsants; Cinnamates; Cyclopropanes; Drug Synergism; GTP-Binding Proteins; Guanidines; Haloperidol; Hippocampus; Ligands; Male; N-Methylaspartate; Neurons; Neuropeptide Y; Pentazocine; Pertussis Toxin; Pyramidal Cells; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Receptors, sigma; Virulence Factors, Bordetella | 1994 |
Processing of photic information within the intergeniculate leaflet of the lateral geniculate body: assessed by neuropeptide Y immunoreactivity in the suprachiasmatic nucleus of rats.
Topics: Animals; Circadian Rhythm; Dizocilpine Maleate; Geniculate Bodies; Hypothalamus; Kainic Acid; Male; N-Methylaspartate; Neural Pathways; Neuropeptide Y; Photic Stimulation; Rats; Rats, Wistar; Suprachiasmatic Nucleus; Time Factors | 1993 |
Hyperprolactinemia suppresses the luteinizing hormone responses to N-methyl-D-aspartate, epinephrine, and neuropeptide-Y in male rats.
Topics: Adrenalectomy; Animals; Drug Implants; Epinephrine; Hyperprolactinemia; Luteinizing Hormone; Male; N-Methylaspartate; Neuropeptide Y; Norepinephrine; Orchiectomy; Prolactin; Rats; Rats, Sprague-Dawley; Testosterone | 1993 |
Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning.
Topics: Acetylcholine; Animals; Anticonvulsants; Cinnamates; Colchicine; Cyclopropanes; Electrophysiology; Guanidines; Hippocampus; Male; N-Methylaspartate; Nerve Fibers; Neuropeptide Y; Neurotoxins; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, sigma | 1996 |
Effects of excitatory amino acids and neuropeptide Y on the discharge activity of suprachiasmatic neurons in rat brain slices.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Circadian Rhythm; Dose-Response Relationship, Drug; Electrophysiology; Excitatory Amino Acid Agonists; Glutamic Acid; Glycine Agents; Male; N-Methylaspartate; Neurons; Neuropeptide Y; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Strychnine; Suprachiasmatic Nucleus | 1997 |
Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.
Topics: Analgesics; Animals; Corpus Striatum; Cyclohexylamines; Dopamine; Dose-Response Relationship, Drug; Ethylamines; Haloperidol; Male; N-Methylaspartate; Neuropeptide Y; Piperidines; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, sigma | 1997 |
Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.
Topics: Animals; Antipsychotic Agents; Dopamine; In Vitro Techniques; Male; N-Methylaspartate; Neuropeptide Y; Nucleus Accumbens; Pentazocine; Peptide Fragments; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Structure-Activity Relationship | 1998 |
Neuropeptide Y-mediated enhancement of NMDA-stimulated [3H]dopamine release from rat prefrontal cortex is reversed by sigma1 receptor antagonists.
Topics: Analgesics; Animals; Cyclohexylamines; Dopamine; Drug Synergism; Male; N-Methylaspartate; Neuropeptide Y; Pentazocine; Prefrontal Cortex; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine | 1998 |
Glutamate-stimulated neuropeptide Y mRNA expression in the rat dentate gyrus: a prominent role of metabotropic glutamate receptors.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cycloleucine; Dentate Gyrus; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Glutamic Acid; Hippocampus; Injections; Injections, Intraperitoneal; Male; N-Methylaspartate; Neuropeptide Y; Neuropeptides; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; RNA, Messenger | 1998 |
Neuropeptide-mediated facilitation and inhibition of sensory inputs and spinal cord reflexes in the lamprey.
Topics: Action Potentials; Analgesics; Animals; Baclofen; Behavior, Animal; Bombesin; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Female; GABA Agonists; Lampreys; Male; N-Methylaspartate; Neurons, Afferent; Neuropeptide Y; Reflex; Spinal Cord; Substance P; Swimming; Synapses | 1999 |
Presynaptic and interactive peptidergic modulation of reticulospinal synaptic inputs in the lamprey.
Topics: Animals; Calcitonin Gene-Related Peptide; Excitatory Postsynaptic Potentials; Lampreys; N-Methylaspartate; Nerve Net; Neuropeptide Y; Neuropeptides; Presynaptic Terminals; Spinal Cord; Synaptic Transmission | 2000 |
The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
Topics: Animals; Circadian Rhythm; Cricetinae; Dose-Response Relationship, Drug; In Vitro Techniques; Light; Male; Mesocricetus; N-Methylaspartate; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y; Suprachiasmatic Nucleus; Time Factors | 2001 |
Blockade of the NPY Y5 receptor potentiates circadian responses to light: complementary in vivo and in vitro studies.
Topics: Animals; Circadian Rhythm; Cricetinae; Lighting; Male; Mesocricetus; N-Methylaspartate; Neuropeptide Y; Receptors, Neuropeptide Y; Suprachiasmatic Nucleus | 2004 |
Characterization of striatal cultures with the effect of QUIN and NMDA.
Topics: Animals; Cell Death; Cells, Cultured; Corpus Striatum; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Immunohistochemistry; N-Methylaspartate; NADP; Neurons; Neuropeptide Y; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Quinolinic Acid; Rats; Receptors, N-Methyl-D-Aspartate; Somatostatin; Superoxide Dismutase; Time Factors | 2004 |
Neuropeptide Y and N-methyl-D-aspartic acid interact within the suprachiasmatic nuclei to alter circadian phase.
Topics: Action Potentials; Anesthetics, Local; Animals; Circadian Rhythm; Cricetinae; Microinjections; N-Methylaspartate; Neuropeptide Y; Suprachiasmatic Nucleus; Tetrodotoxin | 2004 |
Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro.
Topics: Animals; Circadian Rhythm; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; N-Methylaspartate; Neuropeptide Y; Receptors, Neuropeptide Y; Suprachiasmatic Nucleus | 2004 |
Cardiovascular responses to chemical stimulation of the hypothalamic arcuate nucleus in the rat: role of the hypothalamic paraventricular nucleus.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arterial Pressure; beta-Endorphin; Cardiovascular System; Glutamate Decarboxylase; Heart Rate; Injections, Intraventricular; Male; N-Methylaspartate; Narcotic Antagonists; Neuropeptide Y; Nitroprusside; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, GABA-A; Receptors, Melanocortin; Receptors, Neuropeptide Y; Receptors, Opioid; Stimulation, Chemical; Sympathetic Nervous System | 2012 |
Tonic γ-aminobutyric acid-ergic activity in the hypothalamic arcuate nucleus is attenuated in the spontaneously hypertensive rat.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arterial Pressure; Baroreflex; Denervation; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Heart Rate; Hypertension; Male; N-Methylaspartate; Neuropeptide Y; Pyridazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2013 |
A Small Potassium Current in AgRP/NPY Neurons Regulates Feeding Behavior and Energy Metabolism.
Topics: Action Potentials; Agouti-Related Protein; Animals; Circadian Rhythm; Diet, High-Fat; Energy Metabolism; Fasting; Feeding Behavior; Hyperphagia; Ion Channel Gating; Mice, Inbred C57BL; Mutation; N-Methylaspartate; Neurons; Neuropeptide Y; Obesity; Small-Conductance Calcium-Activated Potassium Channels | 2016 |
Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment.
Topics: Animals; Apoptosis; Cellular Microenvironment; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Humans; Mice; N-Methylaspartate; Neuropeptide Y; Rats; Retina; Retinal Ganglion Cells; Retinal Neovascularization; Vascular Endothelial Growth Factor A | 2020 |